[Comparison of neostigmine induced reversal of rocuronium in different age children]

Jinzhu Liu1, Zhaoyu Cheng

  • 1Department of Anesthesiology, Tianjin Children's Hospital, Clinical Pediatric College of Tianjin Medical University, Tianjin 300134, China.

Insights

Neostigmine effectively reverses rocuronium-induced neuromuscular blockade in pediatric patients. However, neonates experience longer recovery times compared to infants, young children, and older children, indicating age-related differences in drug response.

Area of Science:

  • Anesthesiology
  • Pediatric Pharmacology
  • Neuromuscular Blockade

Background:

  • Rocuronium is a common neuromuscular blocking agent used in pediatric surgery.
  • Understanding age-specific recovery from neuromuscular blockade is crucial for patient safety.
  • Neostigmine is a standard reversal agent for neuromuscular blockade.

Purpose of the Study:

  • To compare the effectiveness of neostigmine in reversing rocuronium-induced neuromuscular blockade across different pediatric age groups.
  • To evaluate age-related differences in spontaneous and neostigmine-induced recovery times.

Main Methods:

  • A study involving 160 pediatric patients undergoing elective surgery.
  • Patients were divided into four age groups: neonates, infants, young children, and children.
  • Neuromuscular block was monitored using acceleromyography; neostigmine or saline was administered for reversal.

Main Results:

  • Spontaneous recovery times (T75, TR0.7, recovery index) were significantly longer in neonates compared to other age groups.
  • Neostigmine effectively reversed rocuronium-induced blockade in all age groups.
  • Recovery times following neostigmine administration were also longer in neonates than in infants, young children, and children.

Conclusions:

  • Spontaneous recovery from rocuronium is comparable among infants, young children, and children.
  • Neostigmine demonstrates significant reversal effects across all pediatric age groups.
  • Neonates exhibit prolonged spontaneous and neostigmine-reversed recovery times from rocuronium compared to older pediatric populations.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.7K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
707
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.0K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
909